Case-control study of leukemia and diagnostic radiation exposure
スポンサーリンク
概要
著者
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
HIRAI Hisamaru
Department of Hematology and Oncology, Graduate School of Medicine
-
OMOTO Eijiro
Second Department of Medicine, Okayama University Medical School
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Takeyama Kunihiko
東海大学 医学部
-
Takeyama Kunihiko
国立がんセンター中央病院
-
Takeyama Kunihiko
Department Of Hematology/oncology National Cancer Center Hospital
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
UTSUNOMIYA Atae
Jiaikai Imamura Hospital Branch Hospital
-
Igarashi T
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi Tadahiko
神戸大学 医学研究科腫瘍内科学
-
Igarashi Tadahiko
国立がんセンター東病院
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa Kenichi
国立がんセンター東病院
-
KURIYAMA Kazutaka
Department of Clinical Laboratory Sciences, Hematoimmunology, School of Health Science, Faculty of M
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
OGITA Masami
Sapporo National Hospital
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Kitamura Kunio
名古屋大学 医学系研究科血液･腫瘍内科学
-
YUASA Hidemichi
Department of Oral and Maxillofacial Radiology, School of Dentistry, Aichi-Gakuin University, Divisi
-
HAMAJIMA Nobuyuki
Contributors to special Committee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
UEDA Ryuzo
Contributors to special Committee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
OHNO Ryuzo
Contributors to special Committee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
ASOU Norio
Contributors to special Committee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
UTSUNOMIYA Atae
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia
-
OGURA Michinori
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
TAKIGAWA Nagio
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
UEDA Takanori
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
HIRAOKA Akira
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
MATSUDA Shin
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
KURAISHI Yasunobu
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
NISHIKAWA Kiyoshi
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
UIKE Naokuni
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
TAKESHITA Akihiro
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
TAKEMOTO Yoshinobu
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
SHIMAZAKI Chihiro
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
SAKAMAKI Hisashi
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
INO Teruo
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
MATSUSHIMA Takafumi
Contributors to Special Commitee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
HIRAI Hisamaru
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
NAOE Tomoki
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
TSUBAKI Kazuo
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
TAKAHASHI Masatomo
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
TAKEYAMA Kunihiko
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
MORISHIMA Yasuo
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
ITOH Kuniaki
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
OMOTO Eijiro
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
HODOHARA Keiko
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
TAKAHASHI Isao
Contributors Special Connittee on 'Mechanism and Chemotherapy for Adult Refractory Leukemia'
-
Asou Norio
愛知県がんセンター
-
Asou N
Department Of Hematology Kumamoto University School Of Medicine
-
Asou Norio
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Asou Norio
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Tamura Kazuo
Division Of Medical Oncology And Hematology Department Of Medicine Fukuoka University Hospital
-
Shimazaki Chihiro
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Shimazaki Chihiro
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Hiraoka A
Fifth Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hiraoka Akira
Department Of Hematology And Oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hiraoka Akira
Fifth Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Yuasa Hidemichi
Tsurumi Univ. School Of Dental Medicine Kanagawa Jpn
-
Yuasa Hidemichi
Department Of Oral And Maxillofacial Radiology School Of Dentistry Aichi-gakuin Unviersity
-
Ueda T
Fukui Medical Univ. Fukui Jpn
-
Tsubaki K
Kinki Univ. School Of Medicine Osaka Jpn
-
Tsubaki Kazuo
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Kuriyama K
Blood Immunology Laboratory School Of Health Sciences Faculty Of Medicine And University Hospital Un
-
Kuraishi Yasunobu
国立金沢病院
-
Kuraishi Yasunobu
Idarubicin Study Group Internal Medicine Iii Jikei University School Of Medicine
-
Ino T
Fujita Health Univ. School Of Medicine Toyoake City Jpn
-
Ino Teruo
名古屋大学 第1内科
-
Hamajima Nobuyuki
愛知県がんセンター研究所 疫学･予防部
-
Hamajima Nobuyuki
Department Of Preventive Medicine/biostatistics And Medical Decision Making Nagoya University Gradua
-
Takigawa Nagio
Contributors To Special Commitee On 'mechanism And Chemotherapy For Adult Refractory Leukemia&a
-
Hirai Hisamaru
Department Of Hematology And Oncology Graduate School Of Medicine
-
Hodohara Keiko
Contributors Special Connittee On 'mechanism And Chemotherapy For Adult Refractory Leukemia&apo
-
Taniwaki M
Kyoto Prefectural Univ. Medicine Kyoto
-
TAKEYAMA Kunihiko
First Department of Internal Medicine, Nagoya University School of Medicine
-
Oguchi Masahiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Uike N
National Hospital Kyushu Cancer Center Fukuoka Jpn
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Takeshita A
The Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Tomida Akihiro
癌研究会癌化学療法センター
-
Asou Norio
Department Of Hematology Kumamoto University School Of Medicine
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Hamajima Nobuyuki
Cancer Information Service And Surveillance Division Cancer For Cancer Control And Information Servi
-
Hamajima Nobuyuki
Department Of Preventive Medicine
-
SHIMAZAKI Chihiro
Kyoto Prefecture University of Medicine
-
Utsunomiya A
名古屋市立大学 医学研究科腫瘍･免疫内科学
-
Utsunomiya A
Department Of Hematology Imamura-bunin Hospital
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Ueda T
First Department Of Internal Medicine Fukui Medical School
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Takemoto Y
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Takemoto Yoshinobu
Department Of Pathology Okayama University Medical School
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Sakamaki H
Division Of Hematology Tokyo Metropolitan Komagome Hospital
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Hirai Hisamaru
Department Of Hematology And Oncology Faculty Of Medicine University Of Tokyo
-
Hamajima Nobuyuki
Division Of Epidemiology Aichi Cancer Center Research Institute
-
Yokozawa Toshiya
Hematology Division National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Omoto E
Okayama Univ. Medical School Okayama Jpn
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Hiraoka Akira
Department Of Hematology/oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Ueda Ryuzo
Department Of Internal Medicine And Molecular Science Nagoya City University Graduate School Of Medi
-
Yoshino Tadashi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Shimazaki C
Kyoto Prefecture University Of Medicine
-
Takeuchi M
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Ueda Takahiro
First Department Of Internal Medicine Fukui Medical University Idarubicin Study Group
-
Takemoto Yoshinobu
Department Of Pathology Okayama University
-
Itoh Kuniaki
Contributors Special Connittee On 'mechanism And Chemotherapy For Adult Refractory Leukemia&apo
-
Takeshita Akihiro
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Hamajima N
Department Of Preventive Medicine Biostatistics And Medical Decision Making Nagoya University Gradua
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Yoshino Tadashi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Asano Naoko
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Kuraishi Y.
Idarubicin Study Group Internal Medicine Iii Jikei University School Of Medicine
-
Nishikawa Kiyoshi
Contributors To Special Commitee On 'mechanism And Chemotherapy For Adult Refractory Leukemia&a
-
Tsukasaki Kunihiro
The Department Of Haematology Of Atomic Disease Institute Nagasaki University School Of Medicine
-
Kobayashi Takayuki
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Takahashi Isao
Second Department Of Internal Medicine Okayama University Medical School
-
Kuriyama Kazutaka
Department Of Clinical Laboratory Sciences Hematoimmunology School Of Health Science Faculty Of Medi
-
Tamura Amane
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
YUASA Hidemichi
Department of Oral and Maxillofacial Radiology, School of Dentistry, Aichi-Gakuin University, Division of Epidemiology, Aichi Cancer Center Research Institute, Contributors to Special Committee on 'Mechanism and Chemotherapy for Adult Refractory Leuk
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
- Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- Case-control study of leukemia and diagnostic radiation exposure
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Genetic Diagnosis of Community-Acquired MRSA: A Multiplex Real-Time PCR Method for Staphylococcal Cassette Chromosome mec Typing and Detecting Toxin Genes
- Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Clinical Features of Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus in a Tertiary Hospital
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- IgG4-related disease : Historical overview and pathology of hematological disorders
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model.
- Clinical Characteristics of Seven Patients with Aeromonas Septicemia in a Japanese Hospital
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study